0000899243-20-030508.txt : 20201105 0000899243-20-030508.hdr.sgml : 20201105 20201105210840 ACCESSION NUMBER: 0000899243-20-030508 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUY GEOFFREY W DR CENTRAL INDEX KEY: 0000941388 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 201292205 MAIL ADDRESS: STREET 1: ETHICAL HOLDINGS PLC CORPUS CHRISTI STREET 2: HOUSE 9 WEST STREET GODMANCHESTER CITY: CAMBRIDGESHIRE PE18 STATE: A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-03 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0000941388 GUY GEOFFREY W DR SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 1 1 0 0 Executive Chairman Ordinary Shares 2020-11-03 4 M 0 9732 0.0013 A 5511253 D Ordinary Shares 2020-11-03 4 M 0 25913 0.0013 A 5537166 D Ordinary Shares 2020-11-03 4 M 0 15336 0.0013 A 5552502 D Ordinary Shares 2020-11-03 4 M 0 15336 0.0013 A 5567838 D Ordinary Shares 2020-11-03 4 M 0 204552 0.0013 A 5772390 D Ordinary Shares 2020-11-03 4 M 0 9262 0.0013 A 5781652 D Ordinary Shares 2020-11-03 4 M 0 16317 0.0013 A 5797969 D Ordinary Shares 2020-11-03 4 M 0 10704 0.0013 A 5808673 D Ordinary Shares 2020-11-03 4 S 0 56388 8.37 D 5752285 D Ordinary Shares 2020-11-03 4 S 0 140040 8.48 D 5612245 D Ordinary Shares 2020-11-03 4 S 0 92724 8.54 D 5519521 D Ordinary Shares 2020-11-03 4 S 0 18000 8.59 D 5501521 D Stock Options 0.0013 2020-11-03 4 M 0 9740.25 0.00 D 2019-06-24 2025-06-24 Ordinary Shares 9732 8 D Stock Options 0.0013 2020-11-03 4 M 0 25913 0.00 D 2020-02-15 2026-02-15 Ordinary Shares 25913 0 D Stock Options 0.0013 2020-11-03 4 M 0 15336 0.00 D 2019-08-10 2027-08-10 Ordinary Shares 15336 0 D Stock Options 0.0013 2020-11-03 4 M 0 15336 0.00 D 2020-08-10 2027-08-10 Ordinary Shares 15336 0 D Stock Options 0.0013 2020-11-03 4 M 0 204552 0.00 D 2020-08-10 2027-08-10 Ordinary Shares 204552 0 D Stock Options 0.0013 2020-11-03 4 M 0 9262 0.00 D 2019-02-26 2028-02-26 Ordinary Shares 9262 0 D Stock Options 0.0013 2020-11-03 4 M 0 16317 0.00 D 2020-02-26 2028-02-26 Ordinary Shares 16317 0 D Stock Options 0.0013 2020-11-03 4 M 0 10704 0.00 D 2020-03-01 2029-03-01 Ordinary Shares 10704 0 D Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 3, 2020. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2020. Represented by ADS. The price reported in Column 4 is a weighted average price per ordinary share ($100.49 per ADS). These shares were sold in multiple transactions at prices ranging from $100.00 per ADS (or $8.33 per ordinary share) to $100.98 per ADS (or $8.42 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price per ordinary share ($101.81 per ADS). These shares were sold in multiple transactions at prices ranging from $101.00 per ADS (or $8.42 per ordinary share) to $101.99 per ADS (or $8.50 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price per ordinary share ($102.45 per ADS). These shares were sold in multiple transactions at prices ranging from $102.00 per ADS (or $9.50 per ordinary share) to $102.99 per ADS (or $8.58 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price per ordinary share ($103.08 per ADS). These shares were sold in multiple transactions at prices ranging from $103.08 per ADS (or $8.59 per ordinary share) to $103.09 per ADS (or $8.59 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Geoffrey W. Guy 2020-11-05